Pediatric drug development: formulation considerations
- 4 October 2013
- journal article
- review article
- Published by Taylor & Francis Ltd in Drug Development and Industrial Pharmacy
- Vol. 40 (10), 1283-1299
- https://doi.org/10.3109/03639045.2013.850713
Abstract
Absence of safe, effective and appropriate treatment is one of the main causes of high mortality and morbidity rates among the pediatric group. This review provides an overview of pharmacokinetic differences between pediatric and adult population and their implications in pharmaceutical development. Different pediatric dosage forms, their merits and demerits are discussed. Food and Drug Administration Act of 1997 and the Best Pharmaceuticals for Children Act 2002 added 6 months patent extension and exclusivity incentives to pharmaceutical companies for evaluation of medicinal products in children. Prescription Drug User Fee Act and Food and Drug Administration Amendments Act of 2007 made it mandatory for pharmaceutical companies to perform pediatric clinical studies on new drug products. Drug development program should include additional clinical bridge studies to evaluate differences in pharmacokinetics and pharmacodynamics of drugs in adult and child populations. Additionally, pharmaceutical development should consider ease of administration, palatability, appropriate excipients, stability and therapeutic equivalency of pediatric dosage forms. Pediatric population is diverse with individual preferences and demand for custom made dosage formulations. Practically it is not feasible to have different pharmaceutical dosage forms for each group. Hence, an appropriate dosage form that can be administered across pediatric population is warranted.Keywords
This publication has 86 references indexed in Scilit:
- Young HIV-Infected Children and Their Adult Caregivers Prefer Tablets to Syrup Antiretroviral Medications in AfricaPLOS ONE, 2012
- Efficacy, Safety, and Palatability of RACTAB® Formulation Amlodipine Orally Disintegrating TabletsDrugs in R&D, 2011
- Use of the Direct Compression Aid Ludiflash®for the preparation of pellets via wet extrusion/spheronizationDrug Development and Industrial Pharmacy, 2011
- Pediatric antifungal agentsCurrent Opinion in Infectious Diseases, 2009
- Indinavir-Loaded pH-Sensitive Microparticles for Taste Masking: Toward Extemporaneous Pediatric Anti-HIV/AIDS Liquid Formulations with Improved Patient ComplianceAAPS PharmSciTech, 2009
- Medicines for Children: A Matter of TasteThe Journal of Pediatrics, 2008
- Drug-Induced Taste DisordersDrug Safety, 2008
- Clinical Pharmacokinetics in Newborns and Infants Age-related Differences and Therapeutic ImplicationsClinical Pharmacokinetics, 1980
- Clinical Pharmacokinetics in Infants and ChildrenClinical Pharmacokinetics, 1976
- Comparison of serum levels following the administration of oral and parenteral preparations of penicillin to infants and children of various age groupsThe Journal of Pediatrics, 1953